55. 再発性多発軟骨炎 Relapsing polychondritis Clinical trials / Disease details
臨床試験数 : 7 / 薬物数 : 10 - (DrugBank : 9) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 100
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04077736 (ClinicalTrials.gov) | September 10, 2019 | 1/9/2019 | Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis | A Pilot Study of Low Dose IL-2 in the Treatment of Relapsing Polychondritis | Relapsing Polychondritis | Drug: Interleukin-2 | Peking University People's Hospital | NULL | Not yet recruiting | 18 Years | 70 Years | All | 10 | Phase 2 | NULL |